-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Chin-Lin Tseng, DrPH

Articles by Chin-Lin Tseng, DrPH

Impact of a National Specialty E-Consultation Implementation Project on Access

BySusan Kirsh, MD, MPH,Evan Carey, MS,David C. Aron, MD, MS,Omar Cardenas, BS,Glenn Graham, MD, PhD,Rajiv Jain, MD,David H. Au, MD,Chin-Lin Tseng, DrPH,Heather Franklin, MPH,P. Michael Ho, MD, PhD

December 14th 2015

E-consult implementation grew from 12 to 122 VHA sites with multiple specialties. The adjusted e-consult rate of 1.93/100 consults saved significant patient travel miles and costs.

Facility Variation in Utilization of Angiotensin-converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes Mellitus and Chronic Kidney Disease

ByAnjali Tiwari, MBBS, MS,Chin-Lin Tseng, DrPH,Elizabeth F. O. Kern, MD,Miriam Maney, MA, CHPQ,Donald R. Miller, ScD,Leonard Pogach, MD, MBA

February 1st 2007

Diabetes Healthcare Quality Report Cards: How Accurate Are the Grades?

ByLeonard Pogach, MD, MBA,Minge Xie, PhD,Yue Shentue, BA,Chin-Lin Tseng, DrPH,Miriam Maney, MA,Mangala Rajan, MBA,Anjali Tiwari, MD,John Kolassa, PhD,Drew Helmer, MD,Stephen Crystal, PhD,Monika Safford, MD

December 1st 2005

Dual-system Utilization Affects Regional Variation in Prevention Quality Indicators: The Case of Amputations Among Veterans With Diabetes

ByChin-Lin Tseng, DrPH,Jeffrey D. Greenberg, MD, MPH,Drew Helmer, MD, MS,Mangala Rajan, MBA,Anjali Tiwari, MD,Donald Miller, ScD,Stephen Crystal, PhD,Gerald Hawley, RN, MSN,Leonard Pogach, M

November 1st 2004

Latest Updated Articles

Trending on AJMC

Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

Social Factors May Match, Outpace Genetic Risk in Disease Prediction

Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk

A Case for SGLT2 Inhibitors in Non-Diabetic CKD: Sandra Chaparro, MD